Transvaginal cervical measurement and fetal fibronectin testing, used separately or together, do not adequately predict preterm birth and should not be used in routine care of nulliparous women, according to a study in JAMA. Read more
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
